Efficient TAVI in the context of expanding indications - EuroPCR 2021
TAVR-Device Selection & Expanding Indications/Percutaneous Alt. Access (Michael J. Reardon, MD)
TAVR Indications: Low Risk May Be Too Risky
Let’s Talk TAVI Webinar | Should all cases of Aortic Stenosis be considered for TAVI/ TAVR first?
Optimal TAVI outcomes in the active patient - PCR Valves e-Course 2020
Timing and indication for PCI in TAVI patients with coronary disease
Optimising safety and efficiency of TAVI procedures - EuroPCR 2019
Latest innovations and new indications of TAVI | A. Pichard (Washington, USA)
Cardiac Surgery Review Course (Day 3): Current Indication for AVR and TAVI ( Dr. Fahd Makhdom )
APSC Journal Club - TAVI for severe aortic stenosis: Insights from latest trials
TAVI for non-Classical Indication (VIV, AR) | Prof. Victor Guetta
TAVR (Ross Reul, MD)
Challenges and opportunities in high-risk patients undergoing TAVI - EuroPCR 2021
S. Kapadia | TAVR for All? New insights from the low-risk trials
EuroPCR 21: 2V-TAVR
Next generation TAVR device will enable lifetime management of AS patients - EuroPCR 2021
Celebrating 20 Years of TAVR
Planning for a long run: life-time management of bioprosthetic valve implantation - EuroPCR 2021
Journal Club: Protected TAVR with Lars Sondergaard
New, novel Navitor™ TAVI valve with active paravalvular leak-sealing technology - EuroPCR 2021
